New genetic elements linked to neurodegenerative diseases could hold promise for future treatments.
Read More
The results of the largest study to date looking at genetic modifiers of the age of onset of dementia were recently published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association. Cochran, along with collaborators from many other institutes, analyzed the genomes of 340 individuals from the Antioquia family as well as similar families from other studies to gain insight into the genetic landscape of age of disease onset.
Read More
HudsonAlpha is investing in its neurogenomics research through the addition of faculty investigator Nick Cochran, PhD. If his name sounds familiar, that is because Cochran was most recently a senior postdoctoral scientist in the lab of HudsonAlpha President, Science Director, and M. A. Loya Chair in Genomics Rick Myers, PhD.
Read More
A research team from HudsonAlpha and Auburn University College of Veterinary Medicine have identified a gene involved in the development of the cerebral cortex.
Read More
Researchers, like those at the HudsonAlpha Institute for Biotechnology, work tirelessly to gain a better understanding of the cause and pathology of Alzheimer disease in hopes that they can design more effective methods for treating and preventing the disease.
Read More
Nick Cochran, PhD, a senior postdoctoral scientist in the Myers lab at the HudsonAlpha Institute for Biotechnology, has been selected by the National Institutes of Health (NIH) to receive a Pathway to Independence (K99) training grant.
Read More